Stakeholder cooperation in orphan drug development: The Lancet Neurology: June 6, 2016

The Lancet Neurology in conversation with

English - June 07, 2016 14:30 - 11 minutes - 7.81 MB
Life Sciences Science Education stroke alzheimer's epilepsy sleep cerebral multiple sclerosis Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: The Lancet Neurology Conference: Preclinical neurodegenerative disease: towards prevention and early diagnosis

Next Episode: Global burden of stroke: The Lancet Neurology: June 22, 2016

Annemieke Aartsma-Rus and Elizabeth Vroom discuss with Patricia Lobo the developments in Duchenne muscular dystrophy therapy and how this can serve as a paradigm for development of treatment for rare diseases.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv